[Development and regression of dermal corticosteroid atrophy. 4. Concentration dependence of the skin thinning effect of triamcinolone acetonide].
This report describes the results of steroid-induced thinning of the skin caused by triamcinolone acetonide in the following concentrations: 0.2%, 0.1%, 0.05%, 0.01% and 0.001%. We found that all concentrations had an atrophogenic effect.
D000368:Aged; D001284:Atrophy; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000473:pathology*; D006801:Humans; D008875:Middle Aged; D010328:Patch Tests; D012867:Skin / Q000473:pathology; D014222:Triamcinolone Acetonide / Q000009:adverse effects*
D014222:Triamcinolone Acetonide
Untersuchungen über Entstehung und Rückbildung der dermalen Kortikosteroid-Atrophie. 4. Mitt.: Konzentrationsabhängigkeit des hautverdünnenden Effekts von Triamcinolonacetonid.